Advertisement

BMC paid more for Remdesivir to save lives, informs BMC Commissioner

Meanwhile, the demand for Remdesivir has gone up in the past week with a sharp increase in the instances of coronavirus.

BMC paid more for Remdesivir to save lives, informs BMC Commissioner
SHARES

On Wednesday, April 14, BMC Commissioner Iqbal Chahal stated that the civic body of Mumbai, Brihanmumbai Municipal Corporation (BMC), purchased Remdesivir at a higher rate to save lives since there was an acute shortage of the drug in the city, which is currently grappling with the pandemic.

Moreover, Chahal added, more than the rate, the BMC’s priority was to secure enough vials for the patients suffering from the coronavirus who would need the life-saving drug in civic hospitals.

According to reports, Chahal stated, “Remdesivir vials have not been supplied to Haffkine yet, since companies have expressed their inability to do so at once. They can only do it in a staggered manner. Dynamics are changing every day. On Tuesday, India recorded 872 deaths, including 225 in Maharashtra. Remdesivir rates change every day since it is a war-like situation,”

Meanwhile, the demand for Remdesivir has gone up in the past week with a sharp increase in the instances of coronavirus. Therefore, Union minister Mansukh Mandaviya on Wednesday, April 14, stated that decisions have been taken to increase production and supply and reduce the prices of Remdesivir.

In view of the situation, the manufacturers of Remdesivir have volunteered to reduce the price of Remdesivir, the anti-viral drug being used in COVID-19 treatment, to less than INR 3,500 by the end of this week. At present, there is no uniform price of Remdesivir, as it ranges between INR 900 and INR 5,000 per vial.

Read this story in मराठी
RELATED TOPICS
Advertisement
MumbaiLive would like to send you latest news updates